Due Diligence

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

A leader in synthetic oligonucleotide manufacturing wanted to assess the total market size and opportunity

A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space

A diagnostic company wanted to assess the current and expected future landscapes for biopharma oncology genomics research and Dx / CDx

A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.